Description

Sandostatin (octreotide) solution for injections 0.1 mg/ml. 1ml. ampoules №5

Ingredients:

Each 1ml ampoule contains 0.1 mg of octreotide acetate as the active ingredient.

Dosage:

The recommended dosage of Sandostatin solution for injections is determined by the healthcare provider based on the individual’s condition. It is typically administered subcutaneously or intravenously.

Indications:

Sandostatin is indicated for the treatment of acromegaly, carcinoid tumors, and VIPomas. It is also used in the management of symptoms associated with neuroendocrine tumors.

Contraindications:

Do not use Sandostatin if you are allergic to octreotide or any of the ingredients in the product. It is contraindicated in patients with known hypersensitivity to octreotide.

Directions:

Administer Sandostatin as directed by a healthcare professional. Follow the specific instructions provided with the product for proper administration.

Scientific Evidence:

Studies have shown that octreotide, the active ingredient in Sandostatin, effectively inhibits the secretion of various hormones such as growth hormone, insulin, and glucagon. This inhibition helps in the management of conditions like acromegaly and neuroendocrine tumors.

Research published in the Journal of Clinical Endocrinology & Metabolism demonstrated the efficacy of octreotide in reducing tumor size and hormone levels in patients with advanced neuroendocrine tumors, leading to symptom relief and improved quality of life.

Additional Information:

Sandostatin solution for injections should be stored at controlled room temperature and protected from light. It is important to follow proper aseptic techniques during administration to minimize the risk of infection.

Before using Sandostatin, inform your healthcare provider about any existing medical conditions or medications you are taking to avoid potential drug interactions.